Vasim Farooq

The SYNTAX score on its way out or … towards artificial intelligence: part I

Serruys P, Chichareon P, Modolo R, Leaman D, Reiber J, Emanuelsson H, Di Mario C, Pijls NHJ, Morel M, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas C, Davies J, Banning A, Escaned J, Piek J, Echavarria-Pinto M, Taylor C, Thomsen B, Collet C, Pompilio G, Bartorelli A, Glocker B, Dressler O, Stone G, Onuma Y

May 20, 2020 | 10.4244/EIJ-D-19-00543A

The SYNTAX score on its way out or … towards artificial intelligence: part II

Serruys P, Chichareon P, Modolo R, Leaman D, Reiber J, Emanuelsson H, Di Mario C, Pijls NHJ, Morel M, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas C, Davies J, Banning A, Escaned J, Piek J, Echavarria-Pinto M, Taylor C, Thomsen B, Collet C, Pompilio G, Bartorelli A, Glocker B, Dressler O, Stone G, Onuma Y

May 20, 2020 | 10.4244/EIJ-D-19-00543B

Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study

Serruys P, Farooq V, Banning A, Escaned J, Wykrzykowska JJ, Piek J, Dudek D, Ochala A, Hildick-Smith D, Goicolea J, Iñiguez A, Buszman P, Modolo R, Katagiri Y, Kogame N, Onuma Y

June 12, 2019 | 10.4244/EIJ-D-18-00980

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

Escaned J, Banning A, Farooq V, Echavarria-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos C, Stanetic B, Ishibashi Y, Suwannasom P, Kappetein A, Taggart D, Morel M, Van Es G-A, Serruys P

June 10, 2016 | 10.4244/EIJV12I2A36

Forward and back aspiration during ST-elevation myocardial infarction: a feasibility study

Farooq V, Serruys P, Mustafa A, Mamas MA, Malik N, Alhous H, El-Omar M, Hendry C, Rana D, Shelton D, Wright P, Narine N, Clarke B, Keavney B, Fath-Ordoubadi F, Fraser D

April 8, 2016 | 10.4244/EIJV11I14A315

Coronary bifurcation treated with the hybrid mini-crush approach: a potential application of three-dimensional optical coherence tomography to optimise stent apposition

Soltani F, Daghem S, Farooq V, El-Omar M

December 20, 2015 | 10.4244/EIJV11I8A187

Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data

Bourantas C, Serruys P, Nakatani S, Zhang Y-J, Farooq V, Diletti R, Ligthart J, Sheehy A, van Geuns R, McClean D, Chevalier B, Windecker S, Koolen J, Ormiston J, Whitbourn R, Rapoza R, Veldhof S, Onuma Y, Garcia-Garcia H

November 20, 2015 | 10.4244/EIJY14M10_06

The triad of residual ischaemia, plaque burden, and plaque vulnerability: a known known?…a known unknown?...or an unknown unknown?

Farooq V, Di Mario C, Serruys P

October 20, 2015 | 10.4244/EIJV11I6A122

Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention

Vranckx P, Kalesan B, Stefanini G, Farooq V, Onuma Y, Silber S, de Vries T, Jüni P, Serruys P, Windecker S

June 19, 2015 | 10.4244/EIJV11I2A31

Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial

Bourantas C, Farooq V, Zhang Y-J, Muramatsu T, Gogas B, Thuesen L, McClean D, Chevalier B, Windecker S, Koolen J, Ormiston J, Whitbourn R, Dorange C, Rapoza R, Onuma Y, Garcia-Garcia H, Serruys P

March 20, 2015 | 10.4244/EIJY14M04_11

Serial optical coherence tomography of drug-eluting stent in-stent restenosis treated with the Absorb bioresorbable scaffold: an effective treatment?

Farooq V, Mamas MA, Frase D, El-Omar M, Clarke B, Fath-Ordoubadi F

March 20, 2015 | 10.4244/EIJV10I11A224

Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial

Zhang Y-J, Bourantas C, Muramatsu T, Iqbal J, Farooq V, Diletti R, Campos C, Onuma Y, Garcia-Garcia H, Serruys P

October 20, 2014 | 10.4244/EIJV10I6A118

Lessons from acute and late scaffold failures in the ABSORB EXTEND trial: have we really learned them all?

Farooq V, Fraser D, El-Omar M, Mamas MA, Clarke B, Fath-Ordoubadi F

August 19, 2014 | 10.4244/EIJV10I4A73

Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation

Radu M, Räber L, Heo J, Gogas B, Jørgensen E, Kelbæk H, Muramatsu T, Farooq V, Helqvist S, Garcia-Garcia H, Windecker S, Saunamäki K, Serruys P

January 20, 2014 | 10.4244/EIJV9I9A183

The coronary artery bypass graft SYNTAX Score: final five-year outcomes from the SYNTAX-LE MANS left main angiographic substudy

Farooq V, Girasis C, Magro M, Onuma Y, Morel M, Heo J, Garcia-Garcia H, Kappetein A, van den Brand M, Holmes D, Mack M, Feldman T, Colombo A, Stahle E, James S, Carrié D, Fournial G, Van Es G-A, Dawkins K, Mohr F, Morice M, Serruys P

December 27, 2013 | 10.4244/EIJV9I8A170

In vivo assessment of the three-dimensional haemodynamic micro-environment following drug-eluting bioresorbable vascular scaffold implantation in a human coronary artery: fusion of frequency domain optical coherence tomography and angiography

Papafaklis M, Bourantas C, Farooq V, Diletti R, Muramatsu T, Zhang Y-J, Fotiadis D, Onuma Y, Garcia-Garcia H, Michalis L, Serruys P

November 29, 2013 | 10.4244/EIJV9I7A147

Revisiting: “Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients”

Zhang Y-J, Garcia-Garcia H, Farooq V, Bourantas C, Serruys P, Chen S

November 29, 2013 | 10.4244/EIJV9I7A148

The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials

Gogas B, Bourantas C, Garcia-Garcia H, Onuma Y, Muramatsu T, Farooq V, Diletti R, van Geuns R, De Bruyne B, Chevalier B, Thuesen L, Smits P, Dudek D, Koolen J, Windecker S, Whitbourn R, McClean D, Dorange C, Miquel-Hebert K, Veldhof S, Rapoza R, Ormiston J, Serruys P

October 25, 2013 | 10.4244/EIJV9I6A115

Observations from the CREDO-Kyoto three-vessel disease registry: can one adjust for the unadjustable?

Farooq V, Serruys P

August 23, 2013 | 10.4244/EIJV9I4A68

Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: the Svelte Coronary Stent Integrated Delivery System first-in-man trial

Diletti R, Garcia-Garcia H, Bourantas C, van Geuns R, Van Mieghem NM, Agostoni P, Muramatsu T, Farooq V, Spencer R, de Schepper J, Pomeranz M, Stella P, Serruys P

May 21, 2013 | 10.4244/EIJV9I1A18

Vasim Farooq

Latest news